arrow
M

Mehmet Mutlu Meydanlı

university of health sciences-turkey
H指数:20
被引数:1,523

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Survival associated with the use of sentinel lymph node in addition to lymphadenectomy in early-stage cervical cancer treated with surgery alone: A sub-analysis of the Surveillance in Cervical CANcer (SCCAN) collaborative study

早期宫颈癌单纯手术治疗中使用前哨淋巴结和淋巴结清扫术的生存率: 宫颈癌监测 (SCCAN) 合作研究的子分析

2024-11-010
OAAI
Impact of adjuvant treatments and risk factors on survival in 2023 FIGO stage IIB endometrial cancer patients: Turkish Gynecologic Oncology Group Study

2023年FIGO分期IIB期子宫内膜癌患者中,辅助治疗和危险因素对生存的影响:土耳其妇科肿瘤学组研究

2024-09-010
PRE
Survival associated with extent of radical hysterectomy in early-stage cervical cancer: a subanalysis of the Surveillance in Cervical CANcer (SCCAN) collaborative study

早期宫颈癌患者根治性子宫切除程度与生存率的相关性: 宫颈癌监测 (SCCAN) 合作研究的子分析

2023-10-017
PRE
Association of Hospital Surgical Volume With Survival in Early-Stage Cervical Cancer Treated With Radical Hysterectomy
2022-11-304
OA
The annual recurrence risk model for tailored surveillance strategy in patients with cervical cancer

用于宫颈癌患者定制监测策略的年度复发风险模型

2021-11-0129
OAAI
Factors associated with survival after relapse in patients with low-risk endometrial cancer treated with surgery alone
2017-01-0117
OAAI
Prognostic factors and treatment outcomes in surgically-staged non-invasive uterine clear cell carcinoma: a Turkish Gynecologic Oncology Group study

手术分期的非侵入性子宫透明细胞癌的预后因素和治疗结果: 土耳其妇科肿瘤学组研究

2017-01-0112
OAAI
Borderline ovarian tumors: clinical characteristics, management, and outcomes - a multicenter study
2016-10-1819
OAAI